33
ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ, 12, 2017; Вып. 2
22. Smith FB, Lee AJ, Fowkes FG,
Price JF, Rumley A, Lowe GD. Hemo-
static factors as predictors of ischemic heart disease and stroke in the Edin-
burgh Artery Study.
Arterioscler Thromb Vasc Biol.
1997;17(11):3321-3325.
https://doi.org/10.1161/01.atv.17.11.3321
23. Smith A, Patterson C, Yarnell J, Rumley A,
Ben-Shlomo Y, Lowe G.
Which hemostatic markers add to the predictive value of conventional risk
factors for coronary heart disease and ischemic stroke?
The Caerphilly
Study. Circulation.
2005;112:3080-3087.
https://doi.org/10.1161/CIRCULATIONAHA.105.557132
24. De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C. Von Willebrand factor:
an emerging target in stroke therapy.
Stroke.
2012;43(2):599-606.
https://doi.org/10.1161/STROKEAHA.111.628867
25. Wannamethee SG, Whincup PH, Lennon L, Rumley A, Lowe GD. Fibrin
D-dimer, tissue-type plasminogen activator, von
Willebrand factor and risk
of incident stroke in older Men.
Stroke.
2012;43(5):1206-1211.
https://doi.org/10.1161/stroceana.111.636373
26. Yang DT, Flanders MM, Kim H, Rodgers GM. Elevated factor XI activity
levels are associated with an increased odds ratio for cerebrovascular events.
Достарыңызбен бөлісу: